Valiant Organics · NSE: VALIANTORG · BSE: 540145

Q3 FY24 results · Oct–Dec 2023

Valiant Organics reported revenue from operations of ₹141.36 crore (down 43.5% from Q3 FY23) and net loss of ₹7.89 crore for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY24Q3 FY23YoYQ2 FY24QoQ
Revenue from operations141.36250.37−43.5%203.10−30.4%
Other income0.401.45−72.7%3.63−89.1%
Total income141.76251.81−43.7%206.73−31.4%
Profit before share of associates & JVs and tax(8.61)34.69Turned loss6.41Turned loss
Share of profit/(loss) of associates & JVs(1.20)0.000.00
Net profit for the period(7.89)26.08Turned loss4.75Turned loss
EPS, basic (₹)(2.90)8.09Turned loss1.58Turned loss
Net margin (%)-5.610.42.3

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ3 FY24Q3 FY23YoYQ2 FY24QoQ
Revenue from operations141.36217.56−35.0%182.48−22.5%
Other income0.400.66−40.4%0.23+75.6%
Total income141.76218.22−35.0%182.70−22.4%
Profit before tax(8.61)24.50Turned loss5.31Turned loss
Net profit for the period(6.69)18.51Turned loss3.92Turned loss
EPS, basic (₹)(2.46)6.82Turned loss1.44Turned loss
Net margin (%)-4.78.52.1
Consolidated
Filed with BSE
24 Feb 2024, 12:54 IST
Board meeting
13 Feb 2024
Period
01 Oct 2023 to 31 Dec 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
24 Feb 2024, 12:54 IST
Board meeting
13 Feb 2024
Period
01 Oct 2023 to 31 Dec 2023
Review status
Audited
Source
XBRL filing on BSE